Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.14% |
| 2 | Technology | 13.55% |
| 3 | Financials | 11.85% |
| 4 | Consumer Staples | 10.18% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Advanced Micro Devices
AMD
$804B
| – | – |
-8,023,026
| Closed | -$117M |
|
3177
Abercrombie & Fitch
ANF
$4.42B
| – | – |
-36,095
| Closed | -$431K |
|
3178
Aon
AON
$78.5B
| – | – |
-641,401
| Closed | -$76.1M |
|
3179
Algonquin Power & Utilities
AQN
$4.66B
| – | – |
-218,500
| Closed | -$2.09M |
|
|
ARI
3180
Apollo Commercial Real Estate
ARI
$883M
| – | – |
-102,940
| Closed | -$1.94M |
|
|
EFOR
3181
Everforth Inc
EFOR
$886M
| – | – |
-13,794
| Closed | -$669K |
|
3182
Ashland
ASH
$3.05B
| – | – |
-363,168
| Closed | -$22M |
|
|
ASM
3183
Avino Silver & Gold Mines
ASM
$999M
| – | – |
-35,700
| Closed | -$62K |
|
3184
Autohome
ATHM
$2.46B
| – | – |
-247,100
| Closed | -$7.85M |
|
3185
ATI
ATI
$26.2B
| – | – |
-165,492
| Closed | -$2.97M |
|
3186
AngloGold Ashanti
AU
$40.9B
| – | – |
-896,400
| Closed | -$9.65M |
|
3187
Alibaba
BABA
$275B
| – | – |
-231,500
| Closed | -$25M |
|
3188
Brunswick
BC
$5.23B
| – | – |
-251,500
| Closed | -$15.4M |
|
3189
B&G Foods
BGS
$292M
| – | – |
-9,300
| Closed | -$374K |
|
|
3190
Booking.com
BKNG
$145B
| – | – |
-5,029,975
| Closed | -$358M |
|
3191
Blackrock
BLK
$165B
| – | – |
-199,968
| Closed | -$76.7M |
|
|
BLRX
3192
BioLineRX
BLRX
$12.3M
| – | – |
-219
| Closed | -$126K |
|
3193
Brookfield
BN
$103B
| – | – |
-1,099,722
| Closed | -$14.3M |
|
3194
Popular Inc
BPOP
$11B
| – | – |
-189,425
| Closed | -$7.71M |
|
3195
Babcock & Wilcox
BW
$1.39B
| – | – |
-17,980
| Closed | -$1.68M |
|
3196
Caleres
CAL
$418M
| – | – |
-121,500
| Closed | -$3.21M |
|
3197
Cathay General Bancorp
CATY
$4.19B
| – | – |
-98,271
| Closed | -$3.7M |
|
3198
CB Financial Services
CBFV
$184M
| – | – |
-9,700
| Closed | -$275K |
|
3199
Carnival Corporation Ltd
CCL
$37.2B
| – | – |
-419,900
| Closed | -$24.7M |
|
3200
Century Aluminum
CENX
$4.45B
| – | – |
-163,999
| Closed | -$2.08M |
|
Similar funds
Renaissance Technologies's Q2 2017 Portfolio in Review
As of Q2 2017, Renaissance Technologies held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Renaissance Technologies deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Renaissance Technologies's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Renaissance Technologies's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Renaissance Technologies fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Renaissance Technologies's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Renaissance Technologies opened 398 new positions and closed 418 in Q2 2017.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.